<?xml version="1.0" encoding="UTF-8"?>
<p>Using EBV-transformed human B-cells to generate human hybridomas can increase efficiency by as much as 25-fold compared to that of using untransformed PBMCs. Therefore, Investigators often utilize a combination approach of EBV immortalization followed by fusion to isolate human DENV-specific mAbs from naturally infected or vaccinated donors (
 <xref rid="B28" ref-type="bibr">28</xref>, 
 <xref rid="B55" ref-type="bibr">55</xref>).
</p>
